Sunday, May 27, 2018 9:44:35 AM
Each of the group are involved in their own area of expertise.
UofA is studying:
1. Diabetes (study started in February 2017) The study is treating islet cells prior to transplantation into human test subjects.
2. Kidney Ischemia (anticipated start date 4th quarter 2017) Ischemia is a condition that occurs when blood flow to cells, tissues or organs is severely restricted.
3. Normothermic Liver Perfusion (start date to be determined) Normothermic (body temperature), ex vivo (outside the body) liver perfusion (method of irrigation) is an innovative therapy.
UofBC is studying:
1. Retinal Cell Replacement (started June 2016) to determine whether AAGP can help improve the survival of stem cells that are currently being used in human trials to treat retinal blindness.
2. Monoclonal Antibody Production (anticipated start date 4th quarter 2017) Monoclonal antibodies are antibodies that are made by identical immune cells that are all clones of a unique parent cell.
PIS is studying:
1. Immune Cell Cryopreservation Recovery (started June 2017 – anticipated end date 4th quarter 2017) Immune based interventions represent one of the fastest growing, most promising areas of personal medicine. This is particularly true for cancer, which is largely a disease of immune failure.
PKTX is studying:
1. Bone Marrow Recovery (Preliminary stage) Bone marrow is a flexible tissue in the interior of bones.
2. Cord Blood Preservation (preliminary stage) Cord blood is the blood left in the umbilical cord and placenta immediately after a baby is born.
3. Ischemic Stroke Repair (anticipated start 4th quarter 2017) Ischemic Stroke is usually associated with severe disabilities, high recurrence rate and other poor outcomes.
These are all ongoing studies with most out of PKTX’s control. The progress and completion are in the hands of the scientists who are preforming the studies. The significance is, they are all using PKTX’s AAGP ™.
ProtoKinetix Inc., will have success on a number of studies. It is just a matter of time. IMHO
Recent PKTX News
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 06/17/2024 07:15:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 07:13:41 PM
- Form D/A - Notice of Exempt Offering of Securities: [Amend] • Edgar (US Regulatory) • 05/15/2024 09:14:59 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 12:46:59 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM